Join haemato-oncologists with expertise in mantle cell lymphoma and CAR T-cell therapy as they respond to questions from the community oncology, haematology and haemato-oncology communities on current treatment strategies for relapsed or refractory mantle cell lymphoma and the role of CAR T-cell therapy
Watch now: touchhaematologyime.org/manag...
This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
Негізгі бет Managing the practicalities of CAR T-cell therapies in patients with R/R MCL
Пікірлер